Products and Services
Cancer screening (Primary)
Unlock a longer, healthier life with our cutting-edge, proprietary method of primary cancer screening. Our exclusive blood-based biomarker detection system unveils unique biomarkers tailored to identify specific cancers of the lung, breast, pancreas, and ovary. Stay ahead as we continue to discover biomarkers for more cancers, ensuring a brighter, healthier future.
2898 unique biomarkers
Numbers of unique biomarkers to detect primary cancer that we have discovered:
Lung cancer
Pancreatic cancer
Breast cancer
Ovarian cancer
1631 unique biomarkers
1798 unique biomarkers
2514 unique biomarkers
Cancer Screening (Recurrence)
Gain the upper hand in your cancer journey with our revolutionary approach to detecting recurrent cancer. Our proprietary blood-based biomarker detection system can swiftly detect cancer recurrence, surpassing the capabilities of current methods like CT DNA and PET scans. Don't just wait – act early for timely and targeted therapy. Unleash the power of precision and stay ahead in the fight against cancer.
Numbers of unique biomarkers to detect recurrent cancer that we have discovered:
Metastatic Breast cancer
1195 unique biomarkers
Prediction of Response to Therapy
Step into the future of response prediction with our groundbreaking method. Unlike conventional approaches relying on vague percentages and likelihoods, our method definitively declares whether a patient will be a complete responder, partial responder, or non-responder to defined therapy. Say goodbye to uncertainties – ours is the only definitive method ensuring absolute precision in predicting therapy response. Trucan Sentinel is spearheading a transformative era in healthcare where precision takes precedence and certainty reigns supreme. Stay informed as we progress swiftly to introduce groundbreaking tests for a range of cancers in the near future.
Numbers of unique biomarkers to predict response to therapies that we have discovered:
Melanoma treated with anti PDL1 therapy
Lung Cancer treated with Tyrosine Kinase Inhibitors
Ovarian cancer treated with Taxane + Platinum Chemotherapy
1369 unique biomarkers
2117 unique biomarkers
556 unique biomarkers